Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) Return on equity
Chemed Corporation's return on equity over the twelve months to 30 September 2026 was 29.1%, up 3.9 percentage points from fiscal 2025 (25.3%). Over the past ten years it has ranged from 18.5% (fiscal 2017) to 39.3% (fiscal 2020); the current reading is higher than 36% of that period. That is above the Medical Care Facilities industry median of 5.03% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 25.3% | (1.84) |
| FY2024 | 27.1% | (1.47) |
| FY2023 | 28.6% | (6.52) |
| FY2022 | 35.1% | (0.12) |
| FY2021 | 35.2% | (4.02) |
| FY2020 | 39.3% | 5.88 |
| FY2019 | 33.4% | (2.96) |
| FY2018 | 36.3% | 17.88 |
| FY2017 | 18.5% | (2.52) |
| FY2016 | 21.0% | (1.89) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| CON Concentra Group Holdings Parent, Inc. compare | 47.9% |
| UHS Universal Health Services, Inc. compare | 40.0% |
| CHE Chemed Corporation | 29.1% |
| PACS PACS Group, Inc. compare | 26.5% |
| ENSG The Ensign Group, Inc. compare | 17.0% |
| OPCH Option Care Health, Inc. compare | 16.0% |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 5.90% |
| LFST LifeStance Health Group, Inc. compare | 4.82% |
| DVA DaVita Inc. compare | −277.7% |
| Medical Care Facilities industry median | 5.03% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CHE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement